Statistical Analyses 8.1.1. Baseline Evaluations The baseline evaluation summaries and lis tings will display patient demographics, including age and performance status, PSA and Gleason score at the time of diagnosis. Details and dates of prior hormonal and nonhormonal therapies should be display ed, along with additional PSA measurements that can be used to estimate PSA doubling times (PSADT). Evaluable data on screened, but not enrolled patients, will be presented as listing s.